The Presence of a Circulating Anti-Coagulant in a Male Member of a Hemophiliac Family.
作者信息
Lawrence J S, Johnson J B
出版信息
Trans Am Clin Climatol Assoc. 1941;57:223-31.
Abstract
摘要
相似文献
1
The Presence of a Circulating Anti-Coagulant in a Male Member of a Hemophiliac Family.一个血友病家族男性成员体内循环抗凝物质的存在
Trans Am Clin Climatol Assoc. 1941;57:223-31.
2
High prevalence of anti-cardiolipin antibody, C1q-, C3d-, and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1.无论是否感染1型人类免疫缺陷病毒，血友病患者中抗心磷脂抗体、C1q、C3d和mRF-IgG免疫复合物以及抗核抗体的高患病率。
J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1120-4.
3
Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.血友病患者中的人类Ⅲ型嗜T细胞病毒抗体、淋巴结病与获得性免疫缺陷综合征。一项前瞻性研究的结果
Am J Med. 1986 Mar;80(3):345-50. doi: 10.1016/0002-9343(86)90704-7.
4
The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.天然存在的抗凝血因子VIII抗体对凝血因子VIII凝血抗原免疫放射分析的影响。对一名存在因子VIII抑制物的交叉反应物质阳性（CRM+）血友病患者的观察。
J Lab Clin Med. 1981 Jan;97(1):65-71.
5
A hemophiliac dog colony: genetic studies and coagulation findings in hemophiliac and normal dogs.
Comp Biochem Physiol A Comp Physiol. 1983;75(2):147-51. doi: 10.1016/0300-9629(83)90061-0.
6
Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.人血浆中凝血因子 VIII 凝血蛋白的两种不同形式。凝血酶切割作用、凝血活性差异以及与血管性血友病因子的关联
J Clin Invest. 1984 Feb;73(2):307-16. doi: 10.1172/JCI111215.
7
An immunologic study of spouses and siblings of asymptomatic hemophiliacs.
Blood. 1983 Dec;62(6):1297-9.
8
Immunologic studies in homosexual and hemophiliac subjects with persistent generalized lymphadenopathy: a comparative analysis.
J Allergy Clin Immunol. 1986 Feb;77(2):295-301. doi: 10.1016/s0091-6749(86)80107-5.
9
Hemophilia in context: adjunctive hypnosis for families with a hemophiliac member.血友病相关情况：针对有血友病患者的家庭采用辅助催眠疗法
Fam Process. 1982 Dec;21(4):469-76. doi: 10.1111/j.1545-5300.1982.00469.x.
10
Clinical outcomes associated with anti-coagulant therapy in patients with renal infarction.肾梗死患者抗凝治疗的临床转归。
QJM. 2018 Dec 1;111(12):867-873. doi: 10.1093/qjmed/hcy205.
引用本文的文献
1
Acute Abdominal Crisis in Type A Hemophilia: Unraveling Retroperitoneal Hematoma: A Case Report.A型血友病的急性腹部危机：揭示腹膜后血肿：一例报告。
Am J Case Rep. 2024 Aug 20;25:e944694. doi: 10.12659/AJCR.944694.
2
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells.VIII 因子向 CD4+ T 细胞的转运塑造了其免疫原性，并且需要几种类型的抗原呈递细胞。
Blood. 2023 Jul 20;142(3):290-305. doi: 10.1182/blood.2022018937.
3
The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A.emicizumab（一种双特异性的靶向因子IXa和因子X的抗体）在预防甲型血友病患者出血发作方面的作用。
Ther Adv Hematol. 2018 Oct 10;9(10):319-334. doi: 10.1177/2040620718799997. eCollection 2018 Oct.
4
Product type and other environmental risk factors for inhibitor development in severe hemophilia A.重度A型血友病中抑制剂产生的产品类型及其他环境风险因素
Res Pract Thromb Haemost. 2018 Apr 10;2(2):220-227. doi: 10.1002/rth2.12094. eCollection 2018 Apr.
5
Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.区分血友病和非血友病患者中的狼疮抗凝物和因子 VIII 抑制剂。
Haemophilia. 2018 Sep;24(5):807-814. doi: 10.1111/hae.13565. Epub 2018 Jul 13.
6
Attempts to treat patients with hemophilia, the "royal disease".治疗血友病患者的尝试，即“皇家病”。
Blood Res. 2013 Dec;48(4):235-6. doi: 10.5045/br.2013.48.4.235.
7
Key issues in inhibitor management in patients with haemophilia.血友病患者抑制剂管理中的关键问题。
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s319-29. doi: 10.2450/2013.0246-12. Epub 2013 Dec 3.
Zotero 插件